Yinfa Yan
11Patents
4h-index
19Co-inventors
53Inventor score
Filing activity: Feb 13, 2004 → Nov 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7259165B2 | Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands | Human Necessities | 55 | Expired |
| US7576087B2 | Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands | Human Necessities | 24 | Active |
| US7417047B2 | Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation | Chemistry; Metallurgy | 12 | Active |
| US7238696B2 | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | Chemistry; Metallurgy | 6 | Expired |
| US7482349B2 | Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase | Chemistry; Metallurgy | 4 | Active |
| US10144737B2 | Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11512055B2 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7560470B2 | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | Chemistry; Metallurgy | 0 | Active |
| US7705030B2 | Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation | Chemistry; Metallurgy | 0 | Active |
| US12187684B2 | Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US7700602B2 | Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.